Page 88 - e-book CPG - Bipolar Disorder
P. 88
CLINICAL PRACTICE GUIDELINES MANAGEMENT OF BIPOLAR DISORDER (2ND ED.)
concentration
concentration
concentration
concentration
concentration
concentration
REMARKS REMARKS REMARKS Plasma Plasma Indication REMARKS trough Plasma Indication trough REMARKS Plasma concentration Indication trough REMARKS Plasma Indication trough (mmol/L) REMARKS (mmol/L) Plasma Indication trough 0.8 - 1.2 (mmol/L) Plasma Indication 0.
Indication Acute Acute Therapy Acute Maintenance Acute Acute Acute Evalu thyroid function. valproate in
HEPATIC HEPATIC HEPATIC HEPATIC HEPATIC HEPATIC HEPATIC
RENAL RENAL RENAL RENAL RENAL RENAL RENAL
74 74 74 74 74 74 74
600 - 1800 mg 600 - 1800 mg in divided daily 600 - 1800 mg in divided daily 600 - 1800 mg dose in divided daily dose 600 - 1800 mg in divided daily dose 600 - 1800 mg in divided daily dose 600 - 1800 mg in divided daily dose in divided daily dose dose Quest3+ Product Search Sistem Pe
DOSING GUIDE DOSING GUIDE DOSING GUIDE 600 - 1200 mg 600 - 1200 mg DOSING GUIDE in divided daily 600 - 1200 mg in divided daily DOSING GUIDE dose - 1200 mg 600 in divided daily DOSING GUIDE dose 600 - 1200 mg in divided daily DOSING GUIDE dose 600 - 1200 mg in divided daily dose 600
Maintenance Maintenance therapy Dose Maintenance therapy Dose Maintenance Range therapy Dose Range Maintenance therapy Dose Range Maintenance therapy Dose Range Maintenance therapy Dose Range therapy Dose Range Range Micromedex® Solution [Mobile application software] Micromedex®
3. Micromedex® Solution [Mobile application software]
Invidual product information leaflet 4. Invidual product information leaflet Invidual product information leaflet Invidual product information leaflet Invidual product information leaflet Invidual product information leaflet Invidual product information leaflet
MEDICATION MEDICATION MEDICATION MEDICATION MEDICATION MEDICATION MEDICATION Valproate Valproate Valproate Valproate Valproate Valproate Valproate Source: Source: Source: Source: Source: Source: 5. urce:
1. *A 1. 2. 1. 2. 3. 1. 2. 3. 4. 1. 2. 3. 4. 1. 2. 5. 3. 4. 5. 2. 3. 4. 5. 3. 4. 5. 4. 5. 5.
74
